» Articles » PMID: 15010890

Dietary Boron Intake and Prostate Cancer Risk

Overview
Journal Oncol Rep
Specialty Oncology
Date 2004 Mar 11
PMID 15010890
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Boron affects human steroid hormone levels. Circulating testosterone and estradiol levels have been proposed to modify prostate cancer risk. However, the association between dietary boron intake and the risk of prostate cancer has not been evaluated by any epidemiological study. We explored the association between dietary boron intake and the risk of prostate cancer in the USA. Our analysis was based on data from the third National Health and Nutrition Examination Survey (NHANES III). Cross-sectional case-control study design was employed by comparing boron intake of 95 prostate cancer cases with that of 8,720 male controls. After controlling for age, race, education, smoking, body mass index, dietary caloric intake, and alcohol consumption, increased dietary boron intake was associated with a decreased risk of prostate cancer with a dose-response pattern. The adjusted odds ratio was 0.46 (95% confidence interval: 0.21-0.98) for the highest quartile of boron intake comparing to the lowest quartile (P for trend = 0.0525). The observed association should be interpreted with caution because of the small case sample size and the nature of the cross-sectional study design, but deserve further investigation.

Citing Articles

In vitro cytotoxic and apoptotic effects of boric acid on endometrial adenocarcinoma cell lines (HEC-1B and Ischikawa).

Cil N, Onder E, Damar A, Tabatabaei S, Cabus U, Mete G Med Oncol. 2025; 42(3):79.

PMID: 39971813 PMC: 11839787. DOI: 10.1007/s12032-025-02625-4.


Does Boric Acid Inhibit Cell Proliferation on MCF-7 and MDA-MB-231 Cells in Monolayer and Spheroid Cultures by Using Apoptosis Pathways?.

Bayram D, Ozgocmen M, Celik D, Sarman E, Sevimli M Biol Trace Elem Res. 2023; 202(5):2008-2021.

PMID: 37572183 DOI: 10.1007/s12011-023-03810-0.


Redox Mechanisms Underlying the Cytostatic Effects of Boric Acid on Cancer Cells-An Issue Still Open.

Paties Montagner G, Dominici S, Piaggi S, Pompella A, Corti A Antioxidants (Basel). 2023; 12(6).

PMID: 37372032 PMC: 10294879. DOI: 10.3390/antiox12061302.


Organoboronic acids/esters as effective drug and prodrug candidates in cancer treatments: challenge and hope.

Al-Omari M, Elaarag M, Al-Zoubi R, Al-Qudimat A, Zarour A, Al-Hurani E J Enzyme Inhib Med Chem. 2023; 38(1):2220084.

PMID: 37318308 PMC: 10351539. DOI: 10.1080/14756366.2023.2220084.


Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer.

Tossetta G, Fantone S, Marzioni D, Mazzucchelli R Cancers (Basel). 2023; 15(11).

PMID: 37296999 PMC: 10252740. DOI: 10.3390/cancers15113037.